Deepkinase

DeepKinase is a biotechnology company commercializing a PCT patented technology proteomics platform DoTK (Deep Omics of Tyrosine Kinase) to enable the next-generation precision medicines. Our vision is “turning cancer into a chronic disease”. Since establishment, DeepKinase has been committed to improving the survival rate and overall quality of life for cancer patients by identifying the most effective drugs tailored to the needs of individual patients, and committed to comprehensively supporting the development of new drugs in terms of target discovery, target identification, understanding mechanism of action, signalling network construction, drug repositioning, biomarker discovery, Drug combination and patient stratification etc. DeepKinase “” DoTK(Deep Omics of Tyrosine Kinase)